6 results for "Akash Sabarwal"
Showing 1–6 · 0.21 seconds · RSS
-
Journal Article
Targeting CD70 in cancer: Mechanisms of immune escape and translational opportunities
Abstract CD70, a tightly regulated immune co‐stimulatory ligand under physiological conditions, becomes aberrantly and persistently overexpressed in a wide spectrum of malignancies, including renal cell carcinoma (RCC), glioblastoma and acute myeloid leukaemia. This tumour‐restricted expression…
-
Journal Article
A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress
Receptor tyrosine kinase (RTK), c-Met, is overexpressed and hyper active in renal cell carcinoma (RCC). Most of the therapeutic agents mediate cancer cell death through increased oxidative stress. Induction of c-Met in renal cancer cells promotes the activation of redox-sensitive transcription…
-
Journal Article Full text
Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells
Renal Cell Carcinoma (RCC) often becomes resistant to targeted therapies, and in addition, dose-dependent toxicities limit the effectiveness of therapeutic agents. Therefore, identifying novel drug delivery approaches to achieve optimal dosing of therapeutic agents can be beneficial in managing…
Also available at: DOAJ
-
Journal Article
AXL signaling in cancer: from molecular insights to targeted therapies
Abstract AXL, a member of the TAM receptor family, has emerged as a potential target for advanced-stage human malignancies. It is frequently overexpressed in different cancers and plays a significant role in various tumor-promoting pathways, including cancer cell proliferation, invasion…